Characterization of an anti-Trop-2-SN-38 antibody-drug conjugate (IMMU-132) with potent activity against solid cancers.
David M. Goldenberg
Employment or Leadership Position - Immunomedics
Stock Ownership - Immunomedics
Edmund A Rossi
Employment or Leadership Position - Immunomedics
Serengulam V. Govindan
Employment or Leadership Position - Immunomedics
Thomas M. Cardillo
Employment or Leadership Position - Immunomedics
William J. McBride
Employment or Leadership Position - Immunomedics
Stock Ownership - Immunomedics
Maria Zalath
Employment or Leadership Position - Immunomedics
Gaby Terracina
Employment or Leadership Position - Immunomedics
Preeti Trisal
Employment or Leadership Position - Immunomedics
Robert M. Sharkey
Employment or Leadership Position - Immunomedics